A detailed history of First Commonwealth Financial Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, First Commonwealth Financial Corp holds 7,040 shares of ABBV stock, worth $1.25 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
7,040
Previous 7,072 0.45%
Holding current value
$1.25 Million
Previous $1.21 Million 14.69%
% of portfolio
0.35%
Previous 0.32%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.84 - $199.33 $5,242 - $6,378
-32 Reduced 0.45%
7,040 $1.39 Million
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $113,461 - $132,497
733 Added 11.56%
7,072 $1.21 Million
Q1 2024

May 14, 2024

SELL
$159.82 - $182.1 $95,412 - $108,713
-597 Reduced 8.61%
6,339 $1.15 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $29,721 - $33,473
-216 Reduced 3.02%
6,936 $1.07 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $46,222 - $53,508
346 Added 5.08%
7,152 $1.07 Million
Q2 2023

Aug 10, 2023

BUY
$132.51 - $164.9 $28,754 - $35,783
217 Added 3.29%
6,806 $916,000
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $20,390 - $23,482
-141 Reduced 2.1%
6,589 $1.05 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $562,783 - $674,925
4,069 Added 152.91%
6,730 $1.09 Million
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $68,672 - $87,305
-499 Reduced 15.79%
2,661 $408,000
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $107 - $135
-1 Reduced 0.03%
3,160 $428,000
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $106 - $120
-1 Reduced 0.03%
3,161 $341,000
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $36,823 - $41,023
350 Added 12.45%
3,162 $357,000
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $1,943 - $2,139
19 Added 0.68%
2,812 $305,000
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $2,012 - $2,716
25 Added 0.9%
2,793 $299,000
Q3 2020

Nov 16, 2020

BUY
$85.91 - $100.83 $42,869 - $50,314
499 Added 21.99%
2,768 $243,000
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $166,476 - $222,770
2,269 New
2,269 $223,000
Q1 2019

May 14, 2019

SELL
$77.14 - $90.79 $364,640 - $429,164
-4,727 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $5,156 - $5,732
58 Added 1.24%
4,727 $447,000
Q2 2018

Aug 13, 2018

SELL
$89.78 - $106.23 $18,674 - $22,095
-208 Reduced 4.26%
4,669 $433,000
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $448,732 - $600,895
4,877 New
4,877 $462,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track First Commonwealth Financial Corp Portfolio

Follow First Commonwealth Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Commonwealth Financial Corp , based on Form 13F filings with the SEC.

News

Stay updated on First Commonwealth Financial Corp with notifications on news.